PMC:7228307 / 15940-16631
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 318 | 324-331 | Gene | denotes | FcγRIIb | Gene:2213 |
| 319 | 445-452 | Gene | denotes | FcγRIIc | Gene:9103 |
| 320 | 25-29 | Gene | denotes | FcγR | Gene:2213 |
| 321 | 0-7 | Gene | denotes | FcγRIIc | Gene:9103 |
| 322 | 139-145 | Species | denotes | humans | Tax:9606 |
| 323 | 431-438 | Gene | denotes | FcγRIIa | Gene:2212 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T165 | 67-77 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
| T166 | 215-220 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T167 | 241-245 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
| T168 | 379-390 | Body_part | denotes | cytoplasmic | http://purl.org/sig/ont/fma/fma66835 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T7 | 391-395 | Body_part | denotes | tail | http://purl.obolibrary.org/obo/UBERON_0002415 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T293 | 0-2 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T294 | 14-24 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activating |
| T295 | 25-27 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T296 | 139-145 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
| T297 | 213-220 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cells |
| T298 | 221-223 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T299 | 227-230 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T300 | 241-245 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
| T301 | 324-326 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T302 | 391-395 | http://purl.obolibrary.org/obo/UBERON_0002415 | denotes | tail |
| T303 | 411-421 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activating |
| T304 | 431-433 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T305 | 445-447 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T306 | 475-485 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
| T307 | 515-516 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T308 | 634-641 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T79 | 67-77 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T98 | 215-220 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T12 | 67-77 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 318 | 324-331 | Gene | denotes | FcγRIIb | Gene:2213 |
| 319 | 445-452 | Gene | denotes | FcγRIIc | Gene:9103 |
| 320 | 25-29 | Gene | denotes | FcγR | Gene:2213 |
| 322 | 139-145 | Species | denotes | humans | Tax:9606 |
| 323 | 431-438 | Gene | denotes | FcγRIIa | Gene:2212 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T22 | 139-145 | Species | denotes | humans | NCBItxid:9605 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T99 | 0-439 | Sentence | denotes | FcγRIIc is an activating FcγR whose expression is regulated single nucleotide polymorphism that permits expression in approximately 20% of humans and in whom it is present at low levels on natural killer (NK) and B cells.11 It has arisen by gene duplication/recombination resulting in an extracellular region derived from FcγRIIb, which binds IgG4, and with an ITAM‐containing cytoplasmic tail related to the activating receptor FcγRIIa. |
| T100 | 440-558 | Sentence | denotes | Thus FcγRIIc provides IgG4 with an activation receptor pathway and confers a new biology of IgG4 in these individuals. |
| T101 | 559-691 | Sentence | denotes | Its low frequency in the population may also confound in vivo mAb clinical testing or use, but as yet there is no evidence for this. |
LitCovid-sample-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T7 | 391-395 | Body_part | denotes | tail | http://purl.obolibrary.org/obo/UBERON_0002415 |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T164 | 67-77 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
| T165 | 215-220 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T166 | 241-245 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
| T167 | 379-390 | Body_part | denotes | cytoplasmic | http://purl.org/sig/ont/fma/fma66835 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T99 | 0-439 | Sentence | denotes | FcγRIIc is an activating FcγR whose expression is regulated single nucleotide polymorphism that permits expression in approximately 20% of humans and in whom it is present at low levels on natural killer (NK) and B cells.11 It has arisen by gene duplication/recombination resulting in an extracellular region derived from FcγRIIb, which binds IgG4, and with an ITAM‐containing cytoplasmic tail related to the activating receptor FcγRIIa. |
| T100 | 440-558 | Sentence | denotes | Thus FcγRIIc provides IgG4 with an activation receptor pathway and confers a new biology of IgG4 in these individuals. |
| T101 | 559-691 | Sentence | denotes | Its low frequency in the population may also confound in vivo mAb clinical testing or use, but as yet there is no evidence for this. |